Plasmonix’s focus is on the enhancement of luminescent signals through advanced use of metal nanoparticles and the application of its technology in life science and diagnostic assays. Commercialization of other consumer and industrial applications, including cosmetics, apparel, paints, lighting, solar and communications, will be approached through partnerships and collaborations.
The fundamental phenomenon behind Metal Enhanced Luminescence is the discovery that luminescent entities brought within 10 to 30 nanometers of certain metal nanoparticles significantly boost luminescent signal strength. Our products boost signal strength by 25 to 1000 times. This lends itself to the development of a broad range of products aimed at life science and diagnostic opportunities where we can deliver assay and clinical diagnostic products that are, correspondingly, 25 to 1000 times more sensitive.
The foundation of Plasmonix’s science is an extensive patent portfolio licensed from the University of Maryland. We expect to expand this base of intellectual property through relationships with leading researchers in the field.